Multifaceted bioactivity of brown seaweed-derived fucoidan from the Indian Coastline: A natural health product candidate
PLOS One · 2026
DOI: 10.1371/journal.pone.0346712 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Manisha Prajapati und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Botany, University of Delhi, New Delhi, Delhi, India. Hauptthemen laut MEDLINE: Polysaccharides, Seaweed, Biological Products. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Brown seaweeds are rich in bioactive constituents, among which fucoidan a sulphated polysaccharide is particularly noted for its broad-spectrum therapeutic properties. This study explores the multifaceted bioactivity of fucoidan extracted from six brown seaweed species ( Sargassum wightii , Sargassum tenerrimum , Sargassum cinereum , Turbinaria conoides , Padina boergesenii , and Padina tetrastromatica ) collected from the Pudumadam coast, Gulf of mannar region, Tamil Nadu, India. Fucoidan was isolated and structurally characterized using Fourier-transform infrared spectroscopy (FT-IR) and nuclear magnetic resonance (NMR) spectroscopy. The antioxidant capacity of the extracts was assessed through 2,2-diphenyl-1-picrylhydrazyl (DPPH), hydroxyl radical scavenging activity (HRSA), and ferric reducing antioxidant power (FRAP) assays, with Sargassum cinereum showing the highest antioxidant activity (IC₅₀: 0.342 ± 0.01 mg/ml for DPPH; 1.26 ± 0.02 mg/ml for HRSA; 33.17 ± 0.02 mM Fe (II)/g for FRAP). In vitro antidiabetic assays demonstrated that fucoidan from Sargassum wightii exhibited the strongest inhibition of α-amylase and α-D-glucosidase (IC₅₀: 0.042 ± 0.02 mg/ml). Additionally, fucoidan from S. wightii displayed significant cytotoxic activity against MCF-7 human breast cancer cells. These findings underscore the therapeutic promise of brown seaweed-derived fucoidan as a multifunctional agent, supporting its potential application in the formulation of natural health products.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Botany, University of Delhi, New Delhi, Delhi, India.
- Department of Botany, Miranda House, University of Delhi, New Delhi, Delhi, India.
- APC Microbiome Ireland, School of Microbiology, University College Cork, Cork, Ireland.
- All India Institute of Medical Science, New Delhi, Delhi, India.
- Department of Botany, Maitreyi College, University of Delhi, New Delhi, Delhi, India.
ORCID-Profile: Shivankar Agrawal
Zitieren
APA
Prajapati, M., Kumar, D., Agrawal, S., Kumar, D., Baweja, P., & Sahoo, D. (2026). Multifaceted bioactivity of brown seaweed-derived fucoidan from the Indian Coastline: A natural health product candidate. PLOS One. https://doi.org/10.1371/journal.pone.0346712
Vancouver
Prajapati M, Kumar D, Agrawal S, Kumar D, Baweja P, Sahoo D. Multifaceted bioactivity of brown seaweed-derived fucoidan from the Indian Coastline: A natural health product candidate. PLOS One. 2026. doi:10.1371/journal.pone.0346712
BibTeX
@article{Prajapati2026,
author = {Prajapati, Manisha and Kumar, Dharmendra and Agrawal, Shivankar and Kumar, Dhiraj and Baweja, Pooja and Sahoo, Dinabandhu},
title = {Multifaceted bioactivity of brown seaweed-derived fucoidan from the Indian Coastline: A natural health product candidate},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0346712}
}
EUVIMED